ELCC 2016 | Predictive models of tumor response to chemotherapy and radiotherapy in NSCLC

At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Kenneth O’Byrne, MD, from Princess Alexandra Hospital, Queensland University of Technology, Brisbane, Australia, discusses biomarkers, including biomarkers of DNA repair and related pathways, for predicting treatment response to chemotherapy and radiotherapy in patients with non-small cell lung cancer (NSCLC).